Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00364_DB00682_nanopub.RA--YWeL1vRs96aTB5P2Y7cFCJ0k3vAbbd14AKyBShHiY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00364_DB00682 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00364_DB00682 label "DDI between Sucralfate and Warfarin - Sucralfate may reduce the absorption of warfarin. Warfarin should be administered at least 2 hours before or 6 hours after sucralfate administration. Monitor for changes in prothrombin time if sucralfate is initiated, discontinued or dose changed. [drugbank_resource:DB00364_DB00682]" assertion.
- drugbank_resource:DB00364_DB00682 identifier "drugbank_resource:DB00364_DB00682" assertion.
- drugbank_resource:DB00364_DB00682 title "DDI between Sucralfate and Warfarin - Sucralfate may reduce the absorption of warfarin. Warfarin should be administered at least 2 hours before or 6 hours after sucralfate administration. Monitor for changes in prothrombin time if sucralfate is initiated, discontinued or dose changed." assertion.
- drugbank:DB00364 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00364_DB00682 assertion.
- drugbank:DB00682 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00364_DB00682 assertion.